This past week, CTM covered the following issues: China: * Protectionist sentiment in the Global South partners * Anti-dumping measures on chemicals from Japan and U.S. * Trademark and competition case involving Schneider U.S.: * USTR comments on China’s overcapacity, use of trade remedies * Final rule on outbound investment restrictions and

The Biden administration's recent move to restrict outbound investments to China has prompted swift condemnation from Beijing, which characterizes the measures as discriminatory and detrimental to global economic cooperation. As both countries grapple with the implications of these restrictions, concerns are mounting over potential retaliation and the broader

The issue of overcapacity continues to be a top one for the Biden administration, although despite frequently raising it with their Chinese counterparts, no progress has been made.

At the meeting of the Committee on Subsidies and Countervailing Measures (SCM) earlier this week, China and other WTO members debated the issue of capacity/overcapacity, and the chair expressed concern with the level of compliance by WTO Members with their subsidy notification requirements.

Earlier this month, China's Ministry of Commerce (MOFCOM) made a determination to extend its anti-dumping measures on hydroiodic acid originating in Japan and the United States.

The European Union's countervailing duties on Chinese electric vehicles have now been finalized, with the full reasoning of the European Commission available. In terms of the next legal steps, the Commission's determination can now be appealed to the EU courts and can be challenged at the

As the EU is concluding its anti-subsidy investigation on Chinese EVs, the two governments continue their efforts to negotiate a solution to resolve the issue. Recent statements from China have underscored two key points of contention in the ongoing negotiations.